Publikation:

Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia

Lade...
Vorschaubild

Dateien

Amelio_2-qwc8z2qxaf9f3.pdf
Amelio_2-qwc8z2qxaf9f3.pdfGröße: 2.8 MBDownloads: 88

Datum

2021

Autor:innen

Mauriello, Alessandro
Scimeca, Manuel
Massoud, Renato
Novelli, Antonio
Di Lorenzo, Francesca
Finocchiaro, Susanna
Cimino, Carolina
Novelli, Giuseppe
Melino, Gerry
et al.

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Link zur Lizenz

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Open Access Gold
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Cell death & disease. Nature Publishing Group. 2021, 12(8), 762. eISSN 2041-4889. Available under: doi: 10.1038/s41419-021-04058-z

Zusammenfassung

While vaccination is the single most effective intervention to drastically reduce severe disease and death following SARS-CoV-2 infection, as shown in UK and Israel, some serious concerns have been raised for an unusual adverse drug reaction (ADR), including vaccine-induced immune thrombotic thrombocytopenia (VITT) with concurrent low platelets as well as capillary leak syndrome. In fact, the overall safety of the vaccine is highlighted by the low frequency of ADR considering that in UK, by the early June, 40 million first doses and 29 million second doses have been injected; nonetheless, 390 thrombotic events, including 71 fatal events have been reported. Interestingly, the cases reported low platelet counts with the presence of anti-platelet factor-4 (PF4) antibodies, indicating an abnormal clotting reaction. Here, out of three referred cases, we report a post-vaccine clinical case of fatal thrombosis with postmortem examination and whole exome sequencing (WES) analysis, whose pathogenesis appeared associated to a preexisting condition of thrombocytopenia due to myelodysplasia.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690MAURIELLO, Alessandro, Manuel SCIMECA, Ivano AMELIO, Renato MASSOUD, Antonio NOVELLI, Francesca DI LORENZO, Susanna FINOCCHIARO, Carolina CIMINO, Giuseppe NOVELLI, Gerry MELINO, 2021. Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia. In: Cell death & disease. Nature Publishing Group. 2021, 12(8), 762. eISSN 2041-4889. Available under: doi: 10.1038/s41419-021-04058-z
BibTex
@article{Mauriello2021Throm-56539,
  year={2021},
  doi={10.1038/s41419-021-04058-z},
  title={Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia},
  number={8},
  volume={12},
  journal={Cell death & disease},
  author={Mauriello, Alessandro and Scimeca, Manuel and Amelio, Ivano and Massoud, Renato and Novelli, Antonio and Di Lorenzo, Francesca and Finocchiaro, Susanna and Cimino, Carolina and Novelli, Giuseppe and Melino, Gerry},
  note={Article Number: 762}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/56539">
    <dc:contributor>Novelli, Giuseppe</dc:contributor>
    <dc:creator>Di Lorenzo, Francesca</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56539/3/Amelio_2-qwc8z2qxaf9f3.pdf"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Cimino, Carolina</dc:contributor>
    <dc:creator>Mauriello, Alessandro</dc:creator>
    <dc:contributor>Amelio, Ivano</dc:contributor>
    <dc:creator>Finocchiaro, Susanna</dc:creator>
    <dc:contributor>Melino, Gerry</dc:contributor>
    <dcterms:issued>2021</dcterms:issued>
    <dc:creator>Amelio, Ivano</dc:creator>
    <dc:creator>Massoud, Renato</dc:creator>
    <dc:contributor>Di Lorenzo, Francesca</dc:contributor>
    <dcterms:abstract xml:lang="eng">While vaccination is the single most effective intervention to drastically reduce severe disease and death following SARS-CoV-2 infection, as shown in UK and Israel, some serious concerns have been raised for an unusual adverse drug reaction (ADR), including vaccine-induced immune thrombotic thrombocytopenia (VITT) with concurrent low platelets as well as capillary leak syndrome. In fact, the overall safety of the vaccine is highlighted by the low frequency of ADR considering that in UK, by the early June, 40 million first doses and 29 million second doses have been injected; nonetheless, 390 thrombotic events, including 71 fatal events have been reported. Interestingly, the cases reported low platelet counts with the presence of anti-platelet factor-4 (PF4) antibodies, indicating an abnormal clotting reaction. Here, out of three referred cases, we report a post-vaccine clinical case of fatal thrombosis with postmortem examination and whole exome sequencing (WES) analysis, whose pathogenesis appeared associated to a preexisting condition of thrombocytopenia due to myelodysplasia.</dcterms:abstract>
    <dc:creator>Novelli, Giuseppe</dc:creator>
    <dc:language>eng</dc:language>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:creator>Cimino, Carolina</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-14T11:00:06Z</dcterms:available>
    <dc:contributor>Finocchiaro, Susanna</dc:contributor>
    <dc:creator>Scimeca, Manuel</dc:creator>
    <dcterms:title>Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia</dcterms:title>
    <dc:contributor>Massoud, Renato</dc:contributor>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56539/3/Amelio_2-qwc8z2qxaf9f3.pdf"/>
    <dc:creator>Novelli, Antonio</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/56539"/>
    <dc:creator>Melino, Gerry</dc:creator>
    <dc:contributor>Mauriello, Alessandro</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-14T11:00:06Z</dc:date>
    <dc:contributor>Novelli, Antonio</dc:contributor>
    <dc:contributor>Scimeca, Manuel</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Ja
Diese Publikation teilen